| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.26 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |